Academic Journal
Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects.
| Title: | Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects. |
|---|---|
| Authors: | Kim HC; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Republic of Korea., Yang E; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.; Kidney Research Institute, Seoul National University Medical Research Center, Seoul, Republic of Korea., Ban MS; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea., Kim YK; Department of Clinical Pharmacology and Therapeutics, Chungbuk National University College of Medicine and Hospital, Cheongju, Republic of Korea., Hong SH; Hanmi Pharmaceutical Co., Ltd., Seoul, Republic of Korea., Jung J; Hanmi Pharmaceutical Co., Ltd., Seoul, Republic of Korea., Jang IJ; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea., Lee S; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. |
| Source: | Drug design, development and therapy [Drug Des Devel Ther] 2023 Apr 12; Vol. 17, pp. 1115-1124. Date of Electronic Publication: 2023 Apr 12 (Print Publication: 2023). |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE |
| Database: | MEDLINE Complete |
| Full text is not displayed to guests. | Login for full access. |
Accede al texto completo | ResultId |
1 |
|---|---|
| Header |
mdc MEDLINE Complete 37077412 2 Academic Journal academicJournal |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=mdc&AN=37077412 |
| FullText |
Array
(
[0] => Array
(
[Type] => pdflink
)
)
Array ( [Availability] => 1 ) Array ( [0] => Array ( [Url] => https://resolver.ebscohost.com/openurl?authtype=cookie,ip,url,guest&custid=ns017177&groupid=main&profile=ftf&sid=EBSCO:mdc&genre=article&issn=11778881&ISBN=&volume=17&issue=&date=20230412&spage=1115&pages=1115-1124&title=Drug design, development and therapy&atitle=Pharmacokinetics%20and%20Pharmacodynamics%20of%20Esomezol%20DR%2C%20a%20New%20Dual%20Delayed-Release%20Formulation%20of%20Esomeprazole%2020%20Mg%20or%2040%20Mg%2C%20in%20Healthy%20Subjects.&aulast=Kim%20HC&id=DOI:10.2147/DDDT.S392533 [Name] => Full Text Finder (ns017177) [Category] => fullText [Text] => Accede al texto completo [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects.
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AU" term="%22Kim+HC%22">Kim HC</searchLink>; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yang+E%22">Yang E</searchLink>; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.; Kidney Research Institute, Seoul National University Medical Research Center, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ban+MS%22">Ban MS</searchLink>; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+YK%22">Kim YK</searchLink>; Department of Clinical Pharmacology and Therapeutics, Chungbuk National University College of Medicine and Hospital, Cheongju, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Hong+SH%22">Hong SH</searchLink>; Hanmi Pharmaceutical Co., Ltd., Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jung+J%22">Jung J</searchLink>; Hanmi Pharmaceutical Co., Ltd., Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jang+IJ%22">Jang IJ</searchLink>; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink>; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <searchLink fieldCode="JN" term="%22101475745%22">Drug design, development and therapy</searchLink> [Drug Des Devel Ther] 2023 Apr 12; Vol. 17, pp. 1115-1124. <i>Date of Electronic Publication: </i>2023 Apr 12 (<i>Print Publication: </i>2023). ) Array ( [Name] => TypePub [Label] => Publication Type [Group] => TypPub [Data] => Journal Article; Randomized Controlled Trial ) Array ( [Name] => TitleSource [Label] => Journal Info [Group] => Src [Data] => <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Press+Limited%22">Dove Press Limited </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101475745 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1177-8881 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211778881%22">11778881 </searchLink><i>NLM ISO Abbreviation: </i>Drug Des Devel Ther <i>Subsets: </i>MEDLINE ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.2147/DDDT.S392533
)
)
[Languages] => Array
(
[0] => Array
(
[Code] => eng
[Text] => English
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[StartPage] => 1115
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects.
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kim HC
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Yang E
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ban MS
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kim YK
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hong SH
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jung J
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jang IJ
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Lee S
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 12
[M] => 04
[Text] => 2023 Apr 12
[Type] => published
[Y] => 2023
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-electronic
[Value] => 1177-8881
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 17
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Drug design, development and therapy
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |